JENNIFER CALDWELL: Open Payments
NPI 1861922742 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $203 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $135 |
| Janssen Biotech, Inc. | 2 | $52 |
| Incyte Corporation | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Exelixis Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: EPKINLY, ERLEADA, NIKTIMVO, ENHERTU, CABOMETYX, MONOFERRIC, Vanflyta, RYBREVANT.
Industry payments across ME — which companies pay providers there.
